Markets Stocks Economy Crypto Earnings Banking Energy
Home Earnings Feature
Earnings · Exclusive

Kimberly-Clark's Q2 likely steady as costs ease, RBC says

Kimberly-Clark's Q2 likely steady as costs ease, RBC says
Earnings · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Jul 31, 2026 4 min read

Kimberly-Clark, the company behind household names like Kleenex, Huggies, and Cottonelle, is set to report its second-quarter results on Aug. 4. While sales growth is expected to cool, analysts at RBC Capital Markets believe the consumer staples giant can still deliver a steady quarter, thanks to fading cost pressures and ongoing productivity improvements.

RBC projects organic sales growth of just 0.6% for the quarter—a modest figure that reflects a broader slowdown in demand for everyday consumer goods. But the firm argues that the company's bottom line could get a boost from easing input costs and efficiency gains, which may help offset the softer top-line performance.

What's behind the slowdown?

Kimberly-Clark operates in the consumer staples sector, which includes products people buy regularly regardless of economic conditions. That makes the company a relatively defensive investment, but it doesn't make it immune to shifts in consumer behavior. In recent quarters, shoppers have become more price-conscious, trading down to cheaper private-label brands or delaying purchases of non-essential items.

That trend has weighed on volume growth across the industry. Even as prices have risen, the boost from higher prices has started to fade, leaving companies like Kimberly-Clark to rely more on cost control and operational efficiency to protect profits.

RBC's note suggests that Kimberly-Clark's productivity initiatives—programs designed to streamline manufacturing and reduce waste—are starting to pay off. Combined with easing costs for raw materials like pulp and energy, these gains could help the company maintain its profit margins even as sales growth slows.

What to watch on Aug. 4

Investors will be closely watching whether Kimberly-Clark reiterates its 2026 guidance when it reports earnings. The company has previously laid out long-term targets, and reaffirming those goals would signal confidence in its ability to navigate the current environment.

RBC believes the company is on track to do just that, despite the softer sales outlook. If management sticks to its guidance, it could reassure investors that the slowdown is temporary and that the company's strategic initiatives are working.

That said, the consumer staples sector has faced headwinds beyond just slowing demand. Tariff concerns have been a recurring theme, as companies grapple with higher costs on imported goods. While Kimberly-Clark has not specifically flagged tariff issues in this brief, the broader industry has been dealing with such pressures. For context, Colgate recently held its sales forecast despite similar challenges, suggesting that staples companies are finding ways to manage.

What it means for investors

For everyday investors, Kimberly-Clark's upcoming report is a reminder of the dynamics at play in the consumer staples sector. These companies are often seen as safe havens, but they are not growth machines. When sales growth slows, investors look to other metrics—like profit margins and cash flow—to gauge health.

If Kimberly-Clark delivers a steady quarter and reaffirms its guidance, it could provide some stability in a market that has been volatile. The company's defensive characteristics might appeal to investors seeking income and lower risk, especially with mixed signals from the bond market and uncertainty about the Federal Reserve's next moves.

However, it's important to note that a 0.6% organic sales growth figure is hardly exciting. Investors should not expect a dramatic turnaround in the company's top line. Instead, the focus will be on whether management can keep profits growing through efficiency and cost discipline.

RBC's view is that Kimberly-Clark can do just that, but the market will ultimately decide. If the company misses expectations or offers a cautious outlook, shares could come under pressure. Conversely, a reaffirmation of guidance could be seen as a positive signal.

As always, it's wise to consider how this fits into your broader portfolio. Consumer staples stocks like Kimberly-Clark can provide ballast during turbulent times, but they may lag in a strong economic recovery. Diversification remains key.

For now, all eyes are on Aug. 4. The numbers will tell the story, but RBC's analysis suggests that Kimberly-Clark is in a position to weather the slowdown without major disruption.

More from this story

Next article · Don't miss

Bristol-Myers strong quarter tempered by launch delays, RBC says

Bristol-Myers Squibb delivered a strong second quarter, but RBC Capital Markets warns that delays for two key drugs, milvexian and Cobenfy, could keep the stock range-bound. RBC lifted its full-year revenue forecast to $50 billion.

Read the story →
Bristol-Myers strong quarter tempered by launch delays, RBC says